180 related articles for article (PubMed ID: 22844688)
1. Classification of two steroids, prostanozol and methasterone, as Schedule III anabolic steroids under the Controlled Substance Act. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2012 Jul; 77(146):44456-62. PubMed ID: 22844688
[TBL] [Abstract][Full Text] [Related]
2. Classification of three steroids as schedule III anabolic steroids under the Controlled Substances Act. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2009 Dec; 74(232):63603-10. PubMed ID: 20169675
[TBL] [Abstract][Full Text] [Related]
3. Schedules of controlled substances: placement of tapentadol into schedule II. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2009 May; 74(97):23790-3. PubMed ID: 19507329
[TBL] [Abstract][Full Text] [Related]
4. Schedules of controlled substances: placement of pregabalin into schedule V. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2005 Jul; 70(144):43633-5. PubMed ID: 16050051
[TBL] [Abstract][Full Text] [Related]
5. Schedules of controlled substances: placement of 5-methoxy-N,N-dimethyltryptamine into Schedule I of the Controlled Substances Act. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2010 Dec; 75(243):79296-300. PubMed ID: 21171485
[TBL] [Abstract][Full Text] [Related]
6. Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2011 Oct; 76(204):65371-5. PubMed ID: 22016903
[TBL] [Abstract][Full Text] [Related]
7. Schedule of controlled substances: placement of dichloralphenazone into Schedule IV. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2001 Aug; 66(159):42943-4. PubMed ID: 11794309
[TBL] [Abstract][Full Text] [Related]
8. Schedules of controlled substances: placement of lisdexamfetamine into schedule II. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2007 May; 72(85):24532-4. PubMed ID: 17520775
[TBL] [Abstract][Full Text] [Related]
9. Schedules of controlled substances: placement of Zopiclone into schedule IV. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2005 Apr; 70(63):16935-7. PubMed ID: 15806735
[TBL] [Abstract][Full Text] [Related]
10. Schedule of controlled substances; placement of fospropofol into schedule IV. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2009 Oct; 74(192):51234-6. PubMed ID: 19877370
[TBL] [Abstract][Full Text] [Related]
11. Schedules of controlled substances: rescheduling of buprenorphine from schedule V to schedule III. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2002 Oct; 67(194):62354-70. PubMed ID: 12369590
[TBL] [Abstract][Full Text] [Related]
12. Schedules of controlled substances: placement of ezogabine into Schedule V. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2011 Dec; 76(241):77895-99. PubMed ID: 22175093
[TBL] [Abstract][Full Text] [Related]
13. Schedules of controlled substances; placement of 2,5-dimethoxy-4-(n)-propylthiophenethylamine and N-benzylpiperazine into Schedule I of the Controlled Substances Act. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2004 Mar; 69(53):12794-7. PubMed ID: 15029891
[TBL] [Abstract][Full Text] [Related]
14. Schedules of controlled substances; exempt anabolic steroid products. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2008 Mar; 73(52):14178-9. PubMed ID: 18464343
[TBL] [Abstract][Full Text] [Related]
15. Schedules of controlled substances: placement of lacosamide into schedule V. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2009 May; 74(97):23789-90. PubMed ID: 19507328
[TBL] [Abstract][Full Text] [Related]
16. Schedules of controlled substances: placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine into schedule I of the Controlled Substances Act. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2004 Sep; 69(188):58950-3. PubMed ID: 15455477
[TBL] [Abstract][Full Text] [Related]
17. Schedules of controlled substances: placement of perampanel into Schedule III. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2013 Dec; 78(231):72013-6. PubMed ID: 24294637
[TBL] [Abstract][Full Text] [Related]
18. Schedules of controlled substances: temporary placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine into Schedule I. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2003 Apr; 68(65):16427-30. PubMed ID: 12678045
[TBL] [Abstract][Full Text] [Related]
19. Designation of oripavine as a basic class of controlled substance. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2007 Sep; 72(184):54208-10. PubMed ID: 17912784
[TBL] [Abstract][Full Text] [Related]
20. Schedules of controlled substances: removal of naloxegol from control. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2015 Jan; 80(15):3468-70. PubMed ID: 25730920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]